Background: Although the King's College Hospital (KCH) selection criteria for emergency liver transplantation in paracetamolinduced acute liver failure are widely used, strategies to improve sensitivity and facilitate earlier transplantation are required. We investigated the use of arterial blood la
Threshold for albumin as a prognostic marker in acute pancreatitis
β Scribed by Dr. M. P. Holliday; D. Shaw; W. M. Thomas; T. Leese
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 225 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Seventeen out of 30 patients with chronic hepatitis type B with hepatitis B e antigen (HBeAg) in serum remained persistently positive for e antigen, while 13 seroconverted to antibody (antiβHBe) when followed over a period of one to five years. Initial levels of serum hepatitis B virus
## Abstract ## BACKGROUND Chondrosarcoma, the second most frequent primary malignant bone tumor, is classified into 3 grades according to histologic criteria of malignancy. However, a lowβgrade lesion can be difficult to distinguish from a benign enchondroma, whereas some histologically lowβgrade
Clinically significant infections (CSIs) are life-threatening but difficult to diagnose after liver transplantation (LTx). This study investigates the value of procalcitonin (PCT) in addition to c-reactive protein (CRP) and the leukocyte count (LC) as a prognostic marker for CSIs in LTx recipients.
## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of plateletβderived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom
This study was conducted to evaluate the clinical usefulness of serum hCGβ€ in the diagnosis and prognosis of patients (n β«Ψβ¬ 59) with cancers of the oral cavity and oropharynx. As a reference marker we used squamous-cell carcinoma antigen (SCCAg). A blood sample was obtained from all patients before